211 filings
Page 2 of 11
8-K
brnieslk2ej9g1 qg1w5
8 Aug 23
Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2023 Financial Results
4:01pm
8-K
xjisg
20 Jun 23
Submission of Matters to a Vote of Security Holders
7:10pm
EFFECT
ev0m14f 9glpe
9 May 23
Notice of effectiveness
12:15am
8-K
yx7 te3m8ejgqtzrf
8 May 23
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2023 Financial Results
4:01pm
CORRESP
jd8rwu4
4 May 23
Correspondence with SEC
12:00am
DEFA14A
cj3imaezbl rf8m
28 Apr 23
Additional proxy soliciting materials
9:01am
8-K
d9thgqhtfyss11me
24 Apr 23
Other Events
9:01am
8-K
rcfo64u1ncwwo 1fo8
3 Apr 23
Departure of Directors or Certain Officers
4:10pm
UPLOAD
d7gv2fv
31 Mar 23
Letter from SEC
12:00am
8-K
zt8724ws
29 Mar 23
Termination of a Material Definitive Agreement
6:06am
S-8
04e52 us0dv57
28 Mar 23
Registration of securities for employees
5:21pm
8-K
apy2lrn7wjr6xil wxg
28 Mar 23
Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results
4:02pm
8-K
3ne9g341bvy
10 Mar 23
Regulation FD Disclosure
6:22pm
8-K/A
4fpj8u
3 Nov 22
Submission of Matters to a Vote of Security Holders
4:15pm
8-K
mr2h47ml qptop
3 Nov 22
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2022 Financial Results
4:06pm